Clinical Study of Anti-CD56-CAR-T in the Treatment of Relapsed/Refractory NK/T Cell Lymphoma /NK Cell Leukemia
Phase 2
Recruiting
- Conditions
- NK-Cell LeukemiaExtranodal NK T Cell Lymphoma
- Interventions
- Biological: Anti-CD56 CAR T
- First Posted Date
- 2023-07-12
- Last Posted Date
- 2023-07-12
- Target Recruit Count
- 20
- Registration Number
- NCT05941156
- Locations
- 🇨🇳
The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China
Clinical Study of Autologous Stem Cell Transplantation + Anti-CD19 CAR T Cells for B-cell Lymphoma
Phase 2
Recruiting
- Conditions
- B-cell Lymphoma
- Interventions
- Biological: ASCT+CAR-T Cell Infusion
- First Posted Date
- 2023-03-06
- Last Posted Date
- 2023-03-06
- Target Recruit Count
- 30
- Registration Number
- NCT05755828
- Locations
- 🇨🇳
The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China
Clinical Study of Anti-CD1a CAR-T in the Treatment of R/R Acute T-lymphoblastic Leukemia/Lymphoblastic Lymphoma
Phase 2
Recruiting
- Conditions
- Acute T-lymphoblastic LeukemiaAcute T-lymphoblastic Lymphoma
- Interventions
- Biological: CAR-T Cell Infusion
- First Posted Date
- 2023-02-27
- Last Posted Date
- 2023-02-27
- Target Recruit Count
- 20
- Registration Number
- NCT05745181
- Locations
- 🇨🇳
The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China
Clinical Study of the Safety and Efficacy of the R/R B-NHL Regimen With BTK Inhibitor+Anti-CD19 CAR-T Cells
Phase 2
Recruiting
- Conditions
- B-cell Non Hodgkin Lymphoma
- Interventions
- Biological: regimen with BTK inhibitor +Anti-CD19 CAR T cells
- First Posted Date
- 2023-02-24
- Last Posted Date
- 2023-02-24
- Target Recruit Count
- 30
- Registration Number
- NCT05744037
- Locations
- 🇨🇳
The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China
EBV CAR-T Cells for Nasopharyngeal Carcinoma
Early Phase 1
Recruiting
- Conditions
- Nasopharyngeal Carcinoma
- Interventions
- First Posted Date
- 2022-12-16
- Last Posted Date
- 2022-12-19
- Target Recruit Count
- 24
- Registration Number
- NCT05654077
- Locations
- 🇨🇳
The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China
Study on the Treatment of Advanced Malignant Solid Tumor With Revottack and PD-1 Inhibitor
Phase 1
Not yet recruiting
- Conditions
- Advanced Solid Tumor
- Interventions
- Biological: Oncolytic Virus Injection（Revottack）+PD-1
- First Posted Date
- 2022-12-09
- Last Posted Date
- 2022-12-09
- Target Recruit Count
- 10
- Registration Number
- NCT05644509
- Locations
- 🇨🇳
The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China
BGT007 Cell Treatment of Nasopharyngeal Carcinoma
Early Phase 1
Recruiting
- Conditions
- Nasopharyngeal Carcinoma
- Interventions
- First Posted Date
- 2022-11-15
- Last Posted Date
- 2022-12-15
- Target Recruit Count
- 23
- Registration Number
- NCT05616468
- Locations
- 🇨🇳
The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China
The Association of Gut Microbes and Their Metabolites With Post-stroke Depression
- Conditions
- Acute Ischemic Stroke
- First Posted Date
- 2022-06-10
- Last Posted Date
- 2022-06-10
- Target Recruit Count
- 200
- Registration Number
- NCT05414227
- Locations
- 🇨🇳
The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China
Nocardia Cell Wall Skeleton for the Treatment of Diabetic Foot Ulcer Wounds
Phase 4
- Conditions
- Diabetic Foot UlcerTherapy, Directly Observed
- Interventions
- First Posted Date
- 2022-05-10
- Last Posted Date
- 2022-05-10
- Target Recruit Count
- 116
- Registration Number
- NCT05368142
Clinical Study of PSMA-targeted CAR-T Cells in the Treatment of Castration-resistant Prostate Cancer
Phase 1
Recruiting
- Conditions
- Immunotherapy
- Interventions
- Biological: CAR-T cell immunotherapy
- First Posted Date
- 2022-04-29
- Last Posted Date
- 2022-04-29
- Target Recruit Count
- 20
- Registration Number
- NCT05354375
- Locations
- 🇨🇳
Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China
© Copyright 2025. All Rights Reserved by MedPath